IL37 and psoriasis: In the context of psoriasis, where cytokines such as IL-17 and IL-23 may be present at low concentrations or exhibit instability in saliva, protocols customized to account for the specific half-life and stability of these cytokines can improve assay sensitivity and enhance the reliability of the data obtained [175].